Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, August 5 at 2:00 PM EDT

Register Free →

Virtual Human Brain for the Development of Neurosurgical Robotics

Active
ARPA-H 07SBIR / STTR

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The contract seeks to develop a high-resolution, physically and anatomically accurate virtual human brain to serve as a foundational platform for AI-assisted intracranial microsurgery. This initiative aims to enable the advancement of neurosurgical robotics by providing a realistic digital model that replicates the complex structure, biomechanics, and tissue properties of the human brain, allowing for training, simulation, and algorithm development in a controlled environment. The project is part of a broader effort to improve precision and safety in neurosurgical procedures through digital innovation, with the resulting platform intended to support future robotic systems that operate with sub-millimeter accuracy within the delicate confines of the cranial cavity. This solicitation is designated as a Total Small Business Set-Aside under the SBIR/STTR program, restricted to small businesses with fewer than 500 employees, and is administered by ARPA-H within the Department of Health and Human Services. The NAICS code 541715 indicates the focus on research and development in the physical, engineering, and life sciences. Proposals must be submitted by the deadline of September 30, 2027, and the work is expected to be performed within the United States. The goal is to deliver a scientifically rigorous digital brain model that serves as a benchmark for surgical robotics development, advancing the frontier of AI-enabled medical technologies without direct reliance on human trials during the initial development phase.

General Info

Develop high-resolution virtual brain model for AI-assisted neurosurgical robotics; small businesses eligible.

Agency

Department of Health and Human Services → Arpa-HView Agency

NAICS

541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)View NAICS

Place of Performance

Not specified

Set-Aside

SBA

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

1 update
PhaseSolicitation
Posted

Solicitation

Amendment 1

Contract was updated

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment of Health and Human Services → Arpa-H
ContactsNo contacts available
OfficeUS
Organization / Agency
Department of Health and Human Services → Arpa-H
View Agency Profile
Office AddressUS
ContactsNo contact information available

Full Description

Show more
The purpose of this topic aims to take a first step toward AI-assisted intracranial microsurgery by creating a high-resolution, physically and anatomically accurate virtual human brain.

Similar Contracts

Same NAICS industry code

NAICS: 541715
New
Federal
ENTERPRISE PROTOTYPE INITIATIVE CONSORTIUM (EPIC)
Solicitation # FA8750269R001
The Government is soliciting whitepapers for the Enterprise Prototype Initiative Consortium (EPIC), an Other Transaction Agreement (OTA) for Prototype under 10 U.S.C. §4022, administered by the Air Force Research Laboratory. This initiative seeks qualified offerors capable of leading a coordinated prototyping and testing program that accelerates the development and integration of cutting-edge technologies from industry, academia, and government to sustain U.S. military technological advantage. The EPIC agreement will function as an Indefinite Delivery Vehicle with an unlimited ceiling, allowing for multiple Firm-Fixed Price Project Level Orders (PLOs) to be issued over a 120-month ordering period, with an additional 24 months for performance completion. Each PLO will be competitively selected based on technical merit and cost, and successful completion may lead to sole-source follow-on production contracts or OTs, determined on a project-by-project basis. The OT is closed to foreign participation at both the lead and performer levels, and all participants must comply with stringent security requirements, including handling Controlled Unclassified Information up to TS/SCI levels with proper DD254s in place. Offerors must demonstrate robust accounting systems to track government funds and adhere to CMMC and NIST SP 800-171 standards for information security. Whitepapers, limited to ten pages and submitted in PDF or Microsoft Word format, must be received by 12:00 p.m. Eastern Daylight Time on August 12, 2026, via email to designated Agreements Officers and the EPIC inbox. Submissions must directly address the EPIC program objectives as outlined in the Statement of Work and Attachment No. 5. The evaluation will prioritize Technical/Management Capability, focusing on implementation plan feasibility, consortium structure efficiency, member support strategy, and growth potential, with Cost/Price considered only after technical merit is assessed. Awards will be made based on best-value trade-off, not lowest price, and no formal proposals will be requested until whitepapers are evaluated and selected. The contract requires unique entity identifiers, CAGE codes, and SAM registration, with mandatory compliance with Section 889 of the NDAA regarding covered telecommunications equipment and services. Key personnel must undergo background checks, submit annual profiles, and disclose foreign talent program involvement, and organizational conflicts of interest must be identified and mitigated upfront. All project-level deliverables are expected to include software, hardware, technical data, and reports, with payments processed exclusively through Wide Area Work
FA8750 Afrl Rik

POSTED

about 12 hours ago

DEADLINE

in 14 days
View Details
NAICS: 541715
New
Federal
Quantum Benchmarking Initiative (QBI) 2026 Announcement
Solicitation # DARPA-PA-26-02
The Defense Advanced Research Projects Agency (DARPA) is soliciting innovative research through the Quantum Benchmarking Initiative (QBI) 2026 to advance the development of utility-scale fault-tolerant quantum computers and associated computational workflows, with a focus on revolutionary breakthroughs rather than incremental improvements. This initiative, issued under solicitation DARPA-PA-26-02, operates through a series of targeted Quantum Benchmarking Initiative Topics (QBITs), each defining specific research challenges, submission guidelines, and deadlines; proposals must respond exclusively to a published QBIT to be considered. The program is structured around three evaluation stages—assessing a plausible path to a United States Quantum Competitiveness (USQC) goal by 2033, evaluating the technical rigor and risk mitigation of the R&D plan, and verifying the concept’s validation through measurement and demonstration. Awards will be made under Other Transaction (OT) agreements, prioritizing technical merit and innovation through a trade-off analysis rather than lowest-price technically acceptable selection, and funding is expected to be distributed across multiple recipients from both traditional and non-traditional research communities. All participants must comply with stringent Controlled Unclassified Information (CUI) handling protocols as mandated by DoDI 5200.48 and NIST SP 800-171, with documents requiring explicit CUI, Proprietary Business Information, and Export-Controlled markings on all materials and cover sheets, and secure transmission only through approved channels such as encrypted email or DoD SAFE. Contractors and performers must register in the System for Award Management (SAM) with a valid Unique Entity ID, maintain compliance with DFARS 252.204-7000 and 252.204-7012 for safeguarding defense information, and immediately report any unauthorized disclosures or cybersecurity incidents to the QBI Program Security Officer. Performance will be administered under the auspices of DARPA’s Microsystems Technology Office in Arlington, Virginia, with invoicing conducted via the Wide Area WorkFlow system, and all technical data, budget, and source selection information designated as CUI with limited dissemination. Foreign persons may access CUI only under specific, pre-approved conditions tied to authorized DoD missions, and proprietary information must be marked and handled according to individual Other Transaction Agreements. The initiative sets a broad solicitation window through November 14, 2026, but individual QBIT deadlines and performance periods vary and are explicitly defined within
Defense Advanced Research Projects Agcy

POSTED

about 12 hours ago

DEADLINE

in 5 months
View Details
NAICS: 541715
New
Federal
Quantum Benchmarking Initiative Topic (QBIT) Stage A
Solicitation # DARPA-PA-26-02-02
The Defense Advanced Research Projects Agency (DARPA) is soliciting innovative proposals under the Quantum Benchmarking Initiative Topic (QBIT) Stage A, identified by solicitation number DARPA-PA-26-02-02, to advance the design, engineering, testing, and evaluation of utility-scale fault-tolerant quantum computers and associated computational workflows. This initiative aims to foster revolutionary breakthroughs rather than incremental improvements to the current state of quantum computing, with a strong emphasis on attracting new entrants to the field and expanding the breadth of potential solutions. Proposals must be submitted as abstracts through the DARPA BAA portal by November 30, 2026, following strict formatting guidelines outlined in the mandatory QBIT Stage A Abstract Template, which requires detailed sections on the proposed approach, technology challenges, technical capability, and a roadmap for development. The program follows a multi-stage structure, with Stage A focused on developing a system concept report over a six-month period, leading to potential progression to later stages with increased funding and scope. All submissions must be unclassified and adhere to strict data handling protocols defined by the QBI Controlled Unclassified Information (CUI) Guide, which mandates compliance with NIST SP 800-171, DFARS clauses, and export control regulations, including prohibitions on the use of covered telecommunications equipment from designated foreign entities. Proposals will be evaluated under an Other Transaction Authority (OTA) framework, not traditional FAR-based contracting, and are subject to non-traditional terms tailored for research collaboration. The award mechanism will be structured as an Other Transaction Agreement with milestone-based payments tied to deliverables outlined in the attached Task Description Document, Schedule of Milestones and Payments, and Report Requirements. Performance is governed by agreements that include clauses addressing Organizational Conflict of Interest, requiring full disclosure of any prior or ongoing support to DARPA offices and a detailed mitigation plan if applicable. Contractors must also demonstrate the ability to securely handle CUI on compliant systems, report cyber incidents immediately, and restrict access to foreign persons in accordance with public law and export control restrictions. All participants are required to register in SAM, provide a Unique Entity ID and CAGE code, and submit certifications regarding federal tax compliance and felony convictions. Invoicing must occur through the Wide Area Workflow system, and performance may be conducted at any location specified in the executed agreement, though no physical packaging or delivery requirements are imposed. DARPA retains discretion over award decisions through a trade-off process focused on technical merit, mission
Defense Advanced Research Projects Agcy

POSTED

about 12 hours ago

DEADLINE

in 4 months
View Details
NAICS: 541715
New
Federal
Chemistry Research for the Division of Translational Toxicology (DTT)
Solicitation # 75N94026R00002
The National Institute of Environmental Health Sciences (NIEHS), through its Division of Translational Toxicology (DTT), is seeking chemistry research support to advance the National Toxicology Program’s mission of understanding how environmental factors impact human health. This acquisition, identified by solicitation number 75N94026R00002, is a market research effort aimed at identifying qualified vendors capable of providing comprehensive chemistry services across eight functional areas: Logistics and Handling, Characterization, Formulation, Biosample Analysis, Special Studies, Animal Studies, Omics, and In Vitro Assays. The contractor will be responsible for end-to-end chemistry support, including handling hazardous materials, developing and validating analytical methods, conducting toxicokinetic and ADME studies, and ensuring compliance with FDA Good Laboratory Practices, DOT regulations for chemical transport, and NCI guidelines. Work is to be performed at the contractor’s facilities, coordinated closely with DTT in Bethesda, Maryland, where all data and reports must be submitted electronically through the DTT Program Management System in accordance with Section 508 accessibility standards. The anticipated contract structure includes a ten-year base period with an optional six-month extension, and the government expects to use a Cost Plus Fixed-Fee contract type. Evaluation of future proposals will prioritize technical performance, with Logistics and Handling carrying the highest weight at 30%, followed by key areas such as Biosample Method Development and Chemical Identity and Purity at a weight of five. Proposals must include detailed Quality Management Plans, Health and Safety Plans, and IT Security Plans, all of which must be approved prior to work commencement. Key personnel, including the Principal Investigator and Quality Assurance Officer, must be direct employees of the prime contractor, and subcontractors may not fulfill these roles. Facilities involved in animal work must hold AAALAC accreditation and maintain an active IACUC, while the prime contractor must hold DEA licensing for controlled substances. The solicitation requires respondents to submit a single 15-page Capability Statement via email by March 4, 2026, with the document limited to Word or PDF formats. While this posting is for market research and not a formal solicitation, it sets the stage for a future contract with no set-aside classification under NAICS code 541715, and the government will consider all business sizes in the selection process. Financial and administrative details, including payment methods and accounting codes, will be finalized in the subsequent Request for Proposal.
National Institutes Of Health Nichd

POSTED

about 12 hours ago

DEADLINE

in about 1 month
View Details
NAICS: 541715
New
Federal
PID-Based Laser Frequency Stabilization System DevelopmentThe contract entails the design and implementation of a PID feedback control system to externally stabilize laser frequency with real-time calibration and long-term drift correction capabilities. The system must precisely regulate laser output frequency by leveraging proportional-integral-derivative control algorithms tuned for high stability and minimal error accumulation over extended operational periods. Real-time calibration mechanisms are required to continuously adjust for environmental and component-induced variations, while long-term drift correction features must autonomously compensate for thermal, mechanical, and electronic aging effects without manual intervention. The work is to be performed in Boulder, Colorado, under a subcontract arrangement with the National Institute of Standards and Technology, part of the U.S. Department of Commerce. The project falls under NAICS code 541715, indicating it involves scientific research and development services focused on physical, engineering, and related sciences. Proposals must be submitted by August 7, 2026, following a posting date of July 28, 2026. Success will depend on delivering a robust, field-deployable system capable of maintaining laser frequency stability under varying conditions, meeting stringent NIST performance benchmarks for precision metrology and calibration applications.
Department Of Commerce Nist

POSTED

1 day ago

DEADLINE

in 9 days
View Details
NAICS: 541715
New
Federal
Technical Integration and Testing SupportThe contract requires technical integration and testing support for the incorporation of laser modules into the SCALPSS 2.0 stereo camera system, a critical component for space-based optical sensing. The work encompasses precise optical alignment, thermal vacuum testing to simulate space environmental conditions, and full flight qualification to ensure system reliability under extreme operational stresses. All activities must meet stringent NASA standards for spacecraft hardware, with performance validated through rigorous procedural checkpoints and documentation. The place of performance is designated as Hampton, Virginia, where the facilities and expertise necessary for high-fidelity environmental and optical testing are located. This subcontract is issued under the NAICS code 541715 for research and development in physical, engineering, and life sciences, and is managed by the NASA Shared Services Center on behalf of the National Aeronautics and Space Administration. Proposals must be submitted by July 30, 2026, with the solicitation posted on July 28, 2026, indicating a highly time-sensitive procurement window. The successful contractor will be expected to deliver fully integrated and qualified laser modules ready for flight, with all testing results and compliance records maintained to NASA’s archival and audit requirements. No set-aside designation is specified, and the opportunity is open to qualified entities capable of meeting the technical, temporal, and quality demands of this mission-critical support effort.
NASA Shared Services Center

POSTED

1 day ago

DEADLINE

in about 12 hours
View Details

More opportunities from Department of Health and Human Services → Arpa-H

Same awarding agency

NAICS: 541714
SBIR / STTR
Breaking Ground: The First Curative, Durable, Non-Surgical Therapy for Endometriosis
Solicitation # ARPA-H 04
The contract seeks the development of a first-of-its-kind, non-surgical, curative therapy for endometriosis that fundamentally alters the disease course by eliminating or permanently deactivating endometrial implants without invasive procedures. The focus is on novel interventions that reduce lesion size, suppress the inflammatory response triggered by the implants, and prevent recurrence or regrowth, aiming for a durable solution that replaces the current standard of care centered on surgery and symptomatic management. Proposals must demonstrate a clear path toward a treatment that is not palliative but truly transformative, addressing the biological root causes of endometriosis rather than merely mitigating symptoms. This opportunity is issued under ARPA-H 04 by the Advanced Research Projects Agency for Health within the Department of Health and Human Services, and it is designated as a Total Small Business Set-Aside, meaning only small businesses with fewer than 500 employees are eligible to submit proposals under the SBIR/STTR mandate. The solicitation is classified under NAICS code 541714 for research and development in biotechnology, and the response deadline is set for September 30, 2027. The project is expected to yield a therapeutic intervention that significantly advances patient care by removing the need for surgical removal of lesions, thereby addressing the limitations and risks inherent in current treatment paradigms.
Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

about 2 months ago

DEADLINE

in about 1 year
View Details
NAICS: 541714
SBIR / STTR
Universal Platform for Living Adaptive Toxin-removal (UNI-PLAT)
Solicitation # ARPA-H 03
The Universal Platform for Living Adaptive Toxin-removal, or UNI-PLAT, is a federal solicitation under ARPA-H 03 aimed at developing a universal synthetic biology platform designed to create next-generation microbial chassis that can be readily reprogrammed for diverse programmable functions. The primary proof-of-concept focuses on toxin removal for chronic disease management, but the platform is explicitly intended to be adaptable across multiple industries including environmental remediation, biomanufacturing, agriculture, holistic medicine, and therapeutic discovery. The goal is to establish a stable, reliable, and modular microbial system that functions like a plug-and-play tool, enabling rapid customization without compromising performance or robustness across varied operational environments. This initiative is a total small business set-aside under the SBIR/STTR mandate, restricting eligibility to organizations with fewer than 500 employees, and falls under NAICS code 541714 for research and development in the physical, engineering, and life sciences. Managed by the Advanced Research Projects Agency for Health within the Department of Health and Human Services, the solicitation was posted on June 11, 2026, with proposals due by September 30, 2027. While no specific place of performance or point of contact is listed, the project emphasizes cross-sector impact and seeks to catalyze transformative advances in living systems that go beyond the initial toxin-removal application to enable broad, scalable biological solutions.
Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

about 2 months ago

DEADLINE

in about 1 year
View Details
NAICS: 325520
SBIR / STTR
Versatile Bioadhesives
Solicitation # ARPA-H 02
The contract under the title Versatile Bioadhesives, issued by ARPA-H under solicitation number ARPA-H 02, seeks to advance the development of next-generation bioadhesive platforms capable of functioning effectively in clinically challenging environments such as wet, bloody, and dynamically moving tissues. These adhesives must provide robust sealing and bonding across a broad spectrum of tissues and organs while ensuring biocompatibility, controlled degradation, and the potential for reversibility. The technology must support critical applications including hemostasis, prevention of leaks, tissue repair, and fixation of medical devices, with the added capability to deliver biologics or small molecules as part of therapeutic intervention. Successful outcomes will yield deployable solutions that reduce surgical complications and enhance patient outcomes in diverse care settings. This opportunity is designated as a Total Small Business Set-Aside under the SBIR/STTR mandate, exclusively available to small businesses with fewer than 500 employees. It falls under NAICS code 325520, indicating its focus on pharmaceutical and medicinal chemical manufacturing, and is administered by the Department of Health and Human Services through ARPA-H. The solicitation was posted on June 11, 2026, with a response deadline of September 30, 2027. There is no specified place of performance or point of contact listed, and all applications must be submitted through the designated UI link. The emphasis is on translating innovative materials science into safe, reliable, and scalable medical technologies with transformative potential across multiple clinical domains.
Adhesive Manufacturing

POSTED

about 2 months ago

DEADLINE

in about 1 year
View Details
NAICS: 325413
SBIR / STTR
Rapid Comprehensive Diagnostic Test for Multi-System Autoimmune Disease
Solicitation # ARPA-H 06
The contract seeks the development of a rapid, comprehensive diagnostic test for multi-system autoimmune disease, aiming to address a significant unmet need in healthcare by enabling primary care physicians to identify and predict tissue-specific autoimmune manifestations early and accurately. Leveraging recent advances in detecting circulating immune signatures and tissue-specific molecular markers, the desired diagnostic tool must be sufficiently sensitive and specific to support timely clinical decisions and streamline referrals to specialists without requiring complex laboratory infrastructure. The goal is to transform diagnostic workflows by shifting detection from reactive, symptom-driven approaches to proactive, biomarker-based identification of autoimmune activity across multiple organ systems. This solicitation, issued under ARPA-H 06 by the Department of Health and Human Services, is a Total Small Business Set-Aside under the SBIR/STTR mandate, restricted to businesses with fewer than 500 employees, and falls under NAICS code 325413 for medical and diagnostic laboratory services. Proposals are due by September 30, 2027, and the technology must be scalable, clinically viable, and capable of integration into general medical practice. The initiative emphasizes innovation in diagnostic biomarker detection and aims to deliver a point-of-care or near-point-of-care solution that enhances early intervention, reduces diagnostic delays, and improves patient outcomes across the autoimmune disease spectrum.
In-Vitro Diagnostic Substance Manufacturing

POSTED

about 2 months ago

DEADLINE

in about 1 year
View Details